In addition to strategies aimed at neutralizing the functions of TSLP in Atopic Dermatitis (AD) [41], recent research has pursued promising new therapeutic avenues, explored in preclinical trials using murine models. This evidence concerns the gene TSLP and Alzheimer disease.